APUS
Apimeds Pharmaceuticals Us
$3.21
+$0.14 (+4.56%)Oct 29, 2026
Key metrics
The numbers that frame APUS today
- Market cap
- $4.84M
- ROIC
- -54.8%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $1.51
- 52wk High
- $59.70
Growth
Revenue and earnings trend for APUS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about APUS
Is Apimeds Pharmaceuticals Us a good buy?
No. Apimeds Pharmaceuticals Us has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Apimeds Pharmaceuticals Us is selling at a very high price.
What is the market capitalization of APUS?
Apimeds Pharmaceuticals Us's market capitalization is $4.84M.
What is the 52-week high for APUS stock?
The 52-week high for Apimeds Pharmaceuticals Us is $59.70. The current close of $3.21 is 94.6% below that high.
What is the 52-week low for APUS stock?
The 52-week low for Apimeds Pharmaceuticals Us is $1.51. The current close of $3.21 is 112.6% above that low.
Does APUS stock pay dividends?
Apimeds Pharmaceuticals Us does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for APUS?
Apimeds Pharmaceuticals Us's Debt / Equity ratio is 0.14.